title: [IV iron or oral iron in anaemic patient with CKD].
abstract: Population-based study demonstrated that iron deficiency is really frequent, and anaemia not rare. Nevertheless, iron deficiency afflicts anaemic patients at all stages of chronic kidney disease (CKD). Bioavailability of oral iron supplements is highly variable, particularly in case of CKD. Moreover, efficacy is in favour of intravenous (i.v.) iron over oral iron. And safety of i.v. iron sucrose is today definite. Finally, recommended targets, i.e. Hb > 11 g/dl and transferring saturation > 20%, necessitate i.v. iron.
authors: Service de néphrologie, CHU de Nancy, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy. l.frimat@chu-nancy.fr
authors: Luc
authors: L
authors: Frimat
authors: Nathalie
authors: N
authors: Thilly
authors: Stéphanie
authors: S
authors: Boini
mesh_terms: D000284:Administration, Oral; D000740:Anemia / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D001682:Biological Availability; D019587:Dietary Supplements; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications*; D015995:Prevalence
chemical_list: D007501:Iron